IL-13-PE inhibited protein synthesis in IL-13Rα2-positive cancer cells (IC50 between 10 and 50 ng/ml) without TSA, but not in IL-13Rα2-negative cancer cells nor normal cells (IC50 > 1000 ng/ml). The gene discussed is IL13; the disease is cancer.